Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis

Osteoarthritis and Cartilage

Volumn 11, Issue 12, 2003, Pages 864-871

  Smink, J J ^a   Buchholz, I M ^a,c   Hamers, N ^a   van Tilburg, C M ^a   Christis, C ^a   Sakkers, R J B ^a   de Meer, K ^b   van Buul Offers, S C ^a   Koedam, Joost A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Hosp Streekziekenhuis Midden Twente   (Netherlands)

Author keywords

Angiogenesis; Glucocorticoid; Growth plate; Porcine; VEGF

Indexed keywords

CD31 ANTIGEN; EOSIN; GELATINASE B; GLUCOCORTICOID; HEMATOXYLIN; MESSENGER RNA; PREDNISOLONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; CARTILAGE CELL; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENCHONDRAL OSSIFICATION; FEMALE; GROWTH PLATE; GROWTH RETARDATION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METAPHYSIS; MORPHOLOGY; NICK END LABELING; NONHUMAN; OSSIFICATION; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TIBIA; TISSUE SECTION; TRABECULAR BONE;

EID: 0344825363     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1063-4584(03)00187-0     Document Type: Article

References (53)

1. Stevens DA, Williams GR. Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 1999;151:195-204.
2. Hatori M, Klatte KJ, Teixeira CC, Shapiro IM. End labeling studies of fragmented DNA in the avian growth plate: evidence of apoptosis in terminally differentiated chondrocytes. J Bone Miner Res 1995;10:1960-8.
3. Zenmyo M, Komiya S, Kawabata R, Sasaguri Y, Inoue A, Morimatsu M. Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J Pathol 1996;180:430-3.
4. Silvestrini G, Ballanti P, Patacchioli FR, Mocetti P, Di Grezia R, Martin Wedard B, et al. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000;26:33-42.
5. Gerber H-P, Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 2000;10:223-8.
6. . Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
7. Horner A, Bishop NJ, Bord S, Beeton C, Kelsall AW, Coleman N, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 1999;194:519-24.
8. Engsig MT, Chen Q-J, Vu TH, Pedersen A-C, Therkidsen B, Lund LR, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing bones. J Cell Biol 2000;151:879-89.
9. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
10. . Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93:411-22.
11. Blodgett FM, Burgin L, Iezzoni D, Gribetz D, Talbot NB. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med 1956;254:636-41.
12. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am 1996;25:699-717.
13. Rooman R, Koster JG, Bloemen RJ, Gresnigt R, Van Buul-Offers SC. The effect of dexamethasone on body and organ growth of normal and IGF-II transgenic mice. J Endocrinol 1999;163:543-52.
14. Leili S, Scanes CG. The effects of glucocorticoids (dexamethasone) on insulin-like growth factor-I, IGF-binding proteins, and growth in chickens. Proc Soc Exp Biol Med 1998;218:329-33.
15. Ortoft G, Gronbaek H, Oxlund H. Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid. Growth Horm IGF Res 1998;8:251-64.
16. Fritz PC, Ward WE, Atkinson SA, Tenenbaum HC. Tamoxifen attenuates the effects of exogenous glucocorticoid on bone formation and growth in piglets. Endocrinology 1998;139:3399-403.
17. Guo C-Y, Ward W, Cairns P, Atkinson S. Comparative response in growth and bone status to three dexamethasone treatment regimens in infant piglets. Pediatr Res 2000;48:238-43.
18. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GC. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 1992;263:E489-92.
19. Sanchez CP, He Y-Z. Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. Bone 2002;30:692-8.
20. Koedam JA, Smink JJ, Van Buul-Offers SC. Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol 2002;197:35-44.
21. Miller ER, Ullrey DE. The pig as a model for human nutrition. Annu Rev Nutr 1987;7:361-82.
22. Thurston MN, Kember NF. In vitro thymidine labeling in human and porcine growth plates. Cell Tissue Kinet 1985;18:575-82.
23. Reiland S. Growth and skeletal development of the pig. Acta Radiol 1978;358(Suppl):15-22.
24. de Meer K, Smolders HC, Meesterburrie J, de Sain-van der Velden M, Voorbij HAM, Okken A, et al. A single food bolus stimulates albumin synthesis in growing piglets. J Pediatr Gastroenterol Nutr 2001;31:251-7.
25. Weindel K, Marmé D, Weich HA. AIDS associated Kaspoi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 1992;183:1167-74.
26. Melton D, Krieg P, Rebaglati M, Maniatis T, Zinn K, Green MR. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984;12:7035-56.
27. Smink JJ, Koster JG, Gresnigt R, Rooman R, Koedam JA, Van Buul-Offers SC. IGF and IGFBP expression in the growth plate of normal, dexamethasone-treated, and hIGF-II transgenic mice. J Endocrinol 2002;175:143-53.
28. Smink JJ, Gresnigt MG, Hamers N, Koedam JA, Berger R, Van Buul-Offers SC. Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate. J Endocrinol 2003;177:381-8.
29. Kember NF, Walker KVR. Control of bone growth in rats. Nature 1971;229:428-9.
30. Gafni RI, Weise M, Robrecht DT, Meyers JL, Barnes KM, De-Levi S, et al. Catch-up growth is associated with delayed senescence of the growth plate in rabbits. Pediatr Res 2001;50:618-23.
31. Klaus G, Jux C, Fernandez P, Rodriguez J, Himmele R, Mehls O. Suppression of growth plate chondrocyte proliferation by corticosteroids. Pediatr Nephrol 2000;14:612-5.
32. Robson H, Anderson E, Eden OB, Isaksson O, Shalet S. Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation. J Endocrinol 1998;157:225-35.
33. Smink JJ, Koedam JA, Koster JG, Van Buul-Offers SC. Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components. J Endocrinol 2002;174:343-52.
34. Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G, et al. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 1998;139:3296-305.
35. Farnum CE, Wilsman NJ. Condensation of hypertrophic chondrocytes at the chondro-osseous junction of growth plate cartilage in Yucatan swine: relationship to long bone growth. Am J Anat 1989;186:346-58.
36. Takano T, Takigawa M, Suzuki F. Stimulation by glucocorticoids of the differentiated phenotype of chondrocytes and the proliferation of rabbit costal chondrocytes in culture. J Biochem 1985;97:1093-100.
37. Basu A, Haldar S. The relationship between Bcl-2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099-109.
38. Mocetti P, Silvestrini G, Ballanti P, Patacchioli FR, Di Grezia R, Angelucci L, et al. Bcl-2 and Bax expression in cartilage and bone cells after high-dose corticosterone treatment in rats. Tissue Cell 2001;33:1-7.
39. Chappard D, Legrand E, Basle MF, Fromont P, Racineux JL, Rebel A, et al. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 1996;11:676-85.
40. Eberhardt AW, Yeager-Jones A, Blair HC. Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits. Endocrinology 2001;142:1333-40.
41. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis in osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
42. Drescher W, Schneider T, Becker C, Hobolth J, Rüther W, Hansen ES, et al. Selective reduction of bone blood flow by short-term treatment with high-dose methylprednisolone. J Bone Joint Surg Br 2001;83-B:274-7.
43. Abad V, Uyeda JA, Temple HT, De Luca F, Baron F. Determinants of spatial polarity in the growth plate. Endocrinology 1999;140:958-62.
44. Eberhardt W, Schulze M, Engels C, Klasmeier E, Pfeilschifter J. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of NFκB and Ets transcription factors. Mol Endocrinol 2002;16:1752-66.
45. Xu J, Kim G-M, Ahmed SH, Xu J, Yan P, Xu XM, et al. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 2001;21:92-7.
46. Kawahima-Ohya Y, Satakeda H, Kuruta Y, Kawamoto T, Yan W, Akagawa Y, et al. Effects of parathyroid hormone (PTH) and PTH-related peptide on expression of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Endocrinology 1998;139:2120-7.
47. 3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J Bone Miner Res 2002;17:1604-12.
48. Donohue MM, Demay MB. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002;143:3691-4.
49. Wing-hoi C, Kwong-man L, Kwok-pui F, Pauline LP, Kwok-sui L. TGF-β1 is the factor secreted by proliferative chondrocytes to inhibit neo-angiogenesis. J Cell Biochem 2001;S36:79-88.
50. Schuster N, Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 2002;307:1-14.
51. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002;9:6-19.
52. Hellstrom A, Carlsson B, Niklasson A, Segnestam K, Boguszewski M, De Lacerda L, et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002;87:3413-6.
53. Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, Henderson-Briffa KN, et al. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner Res 2003;18:919-24.